
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers

24 Mar 2016 --- OmniActive will present a poster on their OmniLean Salacia Extract Trial in Healthy Human Subjects at Experimental Biology 2016.
Vijaya Juturu Ph.D., F.A.C.N., Senior Manager of Global Scientific and Clinical Affairs, OmniActive Health Technologies Inc. will present findings from the study: "Salacia Extract Improves Post-Prandial Glucose and Insulin Response: A Randomized Double-Blind, Placebo-Controlled, Crossover Study in Healthy Volunteers" at the Experimental Biology Conference, April 2-6 in San Diego, California, USA.
OmniLean provides a comprehensive approach to achieving multiple objectives of healthy metabolism including healthy carbohydrate metabolism, fat metabolism, heart health and weight management in one convenient, low dose ingredient from a traceable, reliable supply chain.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa











